Cohen Cheryl 4
4 · Celldex Therapeutics, Inc. · Filed Jun 17, 2024
Insider Transaction Report
Form 4
Cohen Cheryl
Director
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2024-06-13+16,500→ 16,500 totalExercise: $36.43From: 2025-06-13Exp: 2034-06-13→ Common Stock (16,500 underlying)
Footnotes (1)
- [F1]Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan.